Zobrazeno 1 - 10
of 11
pro vyhledávání: '"D Borducchi"'
Autor:
IAA Barcessat, JTFS Pagani, CA Freitas, PM Maki, D Borducchi, VAQ Mauad, DM Christofolini, AC Griciunas, DEG Camargo, LMAD Santos
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S53- (2023)
Objetivo: Relatar um caso de síndrome Rhnull associada à deficiência de G6PD em paciente submetida a esplenectomia que faz seguimento no Hospital Estadual Mário Covas (HEMC). Material e métodos: Realizado revisão de prontuário, análise cronol
Externí odkaz:
https://doaj.org/article/3965300ef7bd41ee8a70ef6c1334773a
Autor:
EC Chapchap, AL Oliveira, MEAJ Cavalho, PEM Flores, VAQ Mauad, D Borducchi, FR Kerbauy, N Hamerschlak
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S241- (2023)
A Leucemia linfoblástica aguda (LLA) está associada a menor sobrevida global (SG) e livre de progressão (SLP) em adultos devido a múltiplos fatores de risco e menor tolerância aos protocolos de quimioterapia. A estratificação prognóstica infl
Externí odkaz:
https://doaj.org/article/86035ec28b76494a878d1ed2484abe02
Autor:
CS Chiattone, E Miranda, SS Medina, RLR Baptista, J Pereira, SAB Brasil, JV Tavares, KZ Cecyn, FL Nogueira, M Bellosso, DFC Farias, D Borducchi, NS Castro, S Nabhan, PPG Rakde, CCG Macedo, CC Vilarim, M Dias, E Negreiros, VLP Figueiredo, DV Clé, R Schaffel, RD Gaiolla, S Schusterschitz, T Fischer, GF Silva, Y Gonzaga, N Zing, AD Cunha-Jr, JTD Souto-Filho, S Mo, EFO Ribeiro, FB Duarte, RR Sousa, MAL Matedi, MD Pont, N Hamerschlak, G Perini, YS Rabelo, ND Bueno, P Cury, A Hallack-Neto, MT Delamain, M Federico, CA Souza
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S332-S333 (2023)
Objectives: T-cell Brazil project started in April 2017 focusing to collecting epidemiological and clinical data from the most frequent subtypes of PTCL, as an ambispective study collected diagnosis data from January 2015 to December 2022. Our goals
Externí odkaz:
https://doaj.org/article/34934cf181a7482799c281eb9e495689
Autor:
T Fischer, E Miranda, NS Castro, J Pereira, D Borducchi, SS Medina, SAB Brasil, DFC Farias, M Bellesso, JV Tavares, KZ Cecyn, R Schaffel, S Nabhan, FL Nogueira, RLR Baptista, FB Duarte, RR Sousa, MD Pont, CC Vilarim, CCG Macedo, AD Cunh-Junior, PPG Radtke, E Negreiros, N Hamerschlak, VLP Figueiredo, DV Cle, N Zing, M Dias, RD Gaiolla, YBM Gonzaga, JTD Sout-Filho, EFO Ribeiro, GF Silva, S Mo, G Perini, MAL Matedi, A Hallac-Neto, YS Rabelo, M Federico, CA Souza, CS Chiattone
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S361-S362 (2023)
Objectives: To evaluate number of extranodal (EN) sites in nodal PTCL lymphomas (PTCL-NOS, TFH and ALCL ALK+/ALK-) and its specific location as a surrogate for overall survival (OS) and progression free survival (PFS). Also generate hypothesis for fu
Externí odkaz:
https://doaj.org/article/07b0cfa9f254491bbea5b8e5bcc51751
Autor:
KBB Pagnano, ECM Miranda, I Bendit, F Seguro, M Conchon, NN Gonçalves, GH Magalhães, N Clementino, D Borducchi, N Andari, A Coelho, I Luise, L Fogliatto, J Bortolini, R Centrone, C Boquimpani, CA Souza
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S124-S125 (2021)
Aim: This study aimed to evaluate efficacy and safety of generic imatinib (IM) compared to branded imatinib (Glivec) in chronic myeloid leukemia. The primary end-point was the achievement of a major molecular response (MMR) at 12 months and safety. S
Externí odkaz:
https://doaj.org/article/4f6c3b90cb814fe3a1f6cec29e0ef4e1
Autor:
CS Chiattone, E Miranda, J Pereira, KZ Cecyn, NS Castro, SAB Brasil, DFC Farias, M Bellesso, G Duffles, D Borducchi, Y Gonzaga, RLR Baptista, CC Vilarim, CCG Macedo, M Dias, MA Salvino, JV Tavares, S Nabhan, AD Cunha-Junior, N Zing, GF Silva, GN Ribeiro, E Negreiros, R Schaffel, VLP Figueiredo, JTD Souto-Filho, PPG Radtke, MD Pont, FL Nogueira, N Hamerschlak, DV Cle, R Gaiolla, FB Duarte, RR Souza, S Mo, A Hallack-Neto, YS Rabelo, EFO Ribeiro, A Cordeiro, G Perini, ND Bueno, MAL Matedi, P Cury, MT Delamain, M Federico, CA Souza
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S91-S92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbbf79ef3f42ceac9a56429ed8a7fba0
https://doi.org/10.1016/j.htct.2022.09.153
https://doi.org/10.1016/j.htct.2022.09.153
Autor:
M S, Pombo De Oliveira, P, Loureiro, A, Bittencourt, C, Chiattone, D, Borducchi, S M, De Carvalho, H S, Barbosa, M, Rios, A, Sill, F, Cleghorn, W, Blattner
Publikováno v:
International journal of cancer. 83(3)
We describe 195 cases of adult T-cell leukemia/lymphoma (ATLL) reported to the national registry of T-cell malignancies in Brazil between 1994 and 1998. We compared the effect of demographic differences and clinical features of 150 consecutive ATLL c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::393c44132fe9e2782e9ab9f83223451f
https://pubmed.ncbi.nlm.nih.gov/10495418
https://pubmed.ncbi.nlm.nih.gov/10495418
Autor:
Duffles G; Rede Dor Sao Luiz, Sao Paulo, Brazil.; University of Campinas, Hematology and Hemotherapy Centre, Sao Paulo, Brazil., Braga A; Hematology, AC Camargo Cancer Center, Sao Paulo, Brazil., Silveira T; Hematology, AC Camargo Cancer Center, Sao Paulo, Brazil., Novis Y; Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil., Arrais C; Unifesp, Sao Paulo, Brazil., Tucunduva L; Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil., Fonseca AR; Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil., Borducchi D; Rede Dor Sao Luiz, Sao Paulo, Brazil.; Centro Universitário da Faculdade de medicina do ABC, Sao Paulo, Brazil., Neffa P; Rede Dor Sao Luiz, Sao Paulo, Brazil.; Instituto do câncer do estado de São Paulo, ICESP, Sao Paulo, Brazil., Blumm F; Rede Dor Sao Luiz, Sao Paulo, Brazil., Gonçalves MC; Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil., Moreira F; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (FMUSP), Sao Paulo, Brazil., Nucci F; Rede Dor Sao Luiz, Sao Paulo, Brazil.; Hospital universitário Antônio Pedro, Universidade Federal Fluminense, UFF, Niterói, Rio de Janeiro, Brazil., Rego E; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (FMUSP), Sao Paulo, Brazil.; Instituto Dor de pesquisa e Ensino, IDOR, Sao Paulo, Brazil., Rocha V; Rede Dor Sao Luiz, Sao Paulo, Brazil.; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (FMUSP), Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), University of São Paulo (USP), Sao Paulo, SP, Brazil.; Churchill Hospital, Oxford University, Oxford, United Kingdom.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep 10, pp. 1-7. Date of Electronic Publication: 2024 Sep 10.
Autor:
Pombo-de-Oliveira MS; Laboratorio de Marcadores Celulares and Hematology Service, Instituto Nacional de Cancer, Praca Cruz Vermelha 23, CEP 20230-130 Rio de Janeiro, Brazil. mpombo@inca.org.br, Dobbin JA, Loureiro P, Borducchi D, Maia RC, Fernandes MA, Cavalcanti GB Jr, Takemoto S, Franchini G
Publikováno v:
Leukemia research [Leuk Res] 2002 Feb; Vol. 26 (2), pp. 155-61.
Autor:
Pombo-de-Oliveira MS; Cell Marker Laboratory-Department of Hematology of Instituto Nacional de Cancer, Hematologia Clinica, Praça Cruz Vermelha, 23, 7th floor, CEP 20 230 030-Rio de Janeiro, Brazil. mpombo@inca.org.br, Carvalho SM, Borducchi D, Dobbin J, Salvador J, Correa RB, Moellman A, Loureiro P, Chiattone C, Rios M
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2001 Jun; Vol. 42 (1-2), pp. 135-44.